GT201200216A - Nuevos derivados terciarios de 8-hidroxiquinolina-7carboxamida y usos de los mismos. - Google Patents

Nuevos derivados terciarios de 8-hidroxiquinolina-7carboxamida y usos de los mismos.

Info

Publication number
GT201200216A
GT201200216A GT201200216A GT201200216A GT201200216A GT 201200216 A GT201200216 A GT 201200216A GT 201200216 A GT201200216 A GT 201200216A GT 201200216 A GT201200216 A GT 201200216A GT 201200216 A GT201200216 A GT 201200216A
Authority
GT
Guatemala
Prior art keywords
carboxamide
same
hydroxychinoline
new tertiary
tertiary derivatives
Prior art date
Application number
GT201200216A
Other languages
English (en)
Inventor
Del Sordo Simone
Gagliardi Stefania
Mailland Federico
Legora Michela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42026678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201200216(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT201200216A publication Critical patent/GT201200216A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A NUEVOS DERIVADOS TERCIARIOS DE 8-HIDROXIQUINOLINA-7-CARBOXAMIDA Y LAS SALES FARMACÉUTICAMENTE ACEPTABLES DE LOS MISMOS, QUE SON ÚTILES COMO AGENTES ANTIMICÓTICOS Y UN PROCESO PARA SU PREPARACIÓN
GT201200216A 2009-12-29 2012-06-25 Nuevos derivados terciarios de 8-hidroxiquinolina-7carboxamida y usos de los mismos. GT201200216A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09180902A EP2345643A1 (en) 2009-12-29 2009-12-29 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof

Publications (1)

Publication Number Publication Date
GT201200216A true GT201200216A (es) 2014-12-26

Family

ID=42026678

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201200216A GT201200216A (es) 2009-12-29 2012-06-25 Nuevos derivados terciarios de 8-hidroxiquinolina-7carboxamida y usos de los mismos.

Country Status (37)

Country Link
US (1) US8729098B2 (es)
EP (2) EP2345643A1 (es)
JP (1) JP5808754B2 (es)
KR (1) KR101666505B1 (es)
CN (2) CN105384685A (es)
AU (1) AU2010338267B2 (es)
BR (1) BR112012015728A2 (es)
CA (1) CA2783213C (es)
CL (1) CL2012001757A1 (es)
CY (1) CY1116493T1 (es)
DK (1) DK2519505T3 (es)
DO (1) DOP2012000186A (es)
EA (1) EA025563B1 (es)
EC (1) ECSP12012007A (es)
ES (1) ES2540327T3 (es)
GE (1) GEP20156244B (es)
GT (1) GT201200216A (es)
HK (1) HK1178526A1 (es)
HR (1) HRP20150749T1 (es)
HU (1) HUE027220T2 (es)
IL (1) IL220427A (es)
MA (1) MA33829B1 (es)
MX (1) MX2012007748A (es)
MY (1) MY161869A (es)
NI (1) NI201200114A (es)
NZ (1) NZ600788A (es)
PE (1) PE20130179A1 (es)
PL (1) PL2519505T3 (es)
PT (1) PT2519505E (es)
RS (1) RS54096B1 (es)
SG (1) SG181586A1 (es)
SI (1) SI2519505T1 (es)
SM (1) SMT201500182B (es)
TN (1) TN2012000320A1 (es)
UA (1) UA107949C2 (es)
WO (1) WO2011080264A1 (es)
ZA (1) ZA201204347B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345642A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
EP2345641A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives
WO2013124335A1 (en) * 2012-02-24 2013-08-29 F. Hoffmann-La Roche Ag Antiviral compounds
EP2903612B1 (en) * 2012-10-02 2019-07-10 Institut National de la Santé et de la Recherche Médicale (INSERM) Tetrahydroquinoline derivatives and their use as epac inhibitors
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EP4217614A1 (en) 2020-09-22 2023-08-02 Milwaukee Electric Tool Corporation Staple and staple collation
USD976093S1 (en) 2020-09-22 2023-01-24 Milwaukee Electric Tool Corporation Staple collation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US326330A (en) 1885-09-15 Harness-support
US326328A (en) 1885-09-15 Broiler
DE540842C (de) 1930-08-06 1931-12-28 Chinosol Fabrik Akt Ges Verfahren zur Darstellung der 8-Acetyloxychinolin-7-carbonsaeure
NZ304327A (en) 1995-04-08 1999-02-25 Basf Ag Synergistic fungicidal compositions containing a quinoline derivative and a cytochrom b/c inhibitor
US6194413B1 (en) * 1995-11-13 2001-02-27 Smithkline Beecham Corporation Hemoregulatory compounds
EP0927164A1 (en) 1996-09-10 1999-07-07 PHARMACIA & UPJOHN COMPANY 8-hydroxy-7-substituted quinolines as anti-viral agents
DK1031563T3 (da) * 1997-09-30 2006-05-08 Daiichi Seiyaku Co Sulfonylderivater
JP2001294572A (ja) * 2000-02-09 2001-10-23 Dai Ichi Seiyaku Co Ltd 新規スルホニル誘導体
DE60138635D1 (de) 2000-10-12 2009-06-18 Merck & Co Inc Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase
DE60128936T2 (de) 2000-10-12 2008-04-10 Merck & Co, Inc. Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
EP1375486B1 (en) 2001-03-01 2008-10-15 Shionogi & Co., Ltd. Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
DE60322920D1 (de) 2002-08-13 2008-09-25 Shionogi & Co Heterocyclische verbindungen mit hiv-integrase-hemmender wirkung
WO2005033079A1 (ja) * 2003-09-30 2005-04-14 Eisai Co., Ltd. ヘテロ環化合物を含有する新規な抗真菌剤
FR2889192A1 (fr) * 2005-07-27 2007-02-02 Cytomics Systems Sa Composes antifongiques, compositions contenant ces composes et leurs utilisations
JP2009544732A (ja) * 2006-07-26 2009-12-17 ノバルティス アクチエンゲゼルシャフト ウンデカプレニルピロホスフェートシンターゼの阻害剤
WO2009140215A2 (en) * 2008-05-11 2009-11-19 Geraghty, Erin Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
MX2012005429A (es) * 2009-11-10 2012-06-19 Pfizer Inhibidores de n1-pirazoloespirocetona acetil-coa carboxilasa.
WO2011075630A1 (en) * 2009-12-18 2011-06-23 Incyte Corporation Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
EP2345641A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives
EP2345642A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents

Also Published As

Publication number Publication date
TN2012000320A1 (en) 2013-12-12
MX2012007748A (es) 2012-08-03
BR112012015728A2 (pt) 2019-09-24
WO2011080264A1 (en) 2011-07-07
EA201270670A1 (ru) 2013-03-29
HUE027220T2 (hu) 2016-10-28
AU2010338267A2 (en) 2012-07-26
PE20130179A1 (es) 2013-02-24
EP2519505B1 (en) 2015-05-27
SG181586A1 (en) 2012-07-30
CA2783213A1 (en) 2011-07-07
HK1178526A1 (en) 2013-09-13
NZ600788A (en) 2013-08-30
SI2519505T1 (sl) 2015-08-31
PT2519505E (pt) 2015-09-03
HRP20150749T1 (hr) 2015-08-14
MY161869A (en) 2017-05-15
NI201200114A (es) 2013-04-22
UA107949C2 (en) 2015-03-10
ES2540327T3 (es) 2015-07-09
IL220427A (en) 2015-04-30
EA025563B1 (ru) 2017-01-30
RS54096B1 (en) 2015-10-30
DOP2012000186A (es) 2013-01-15
EP2345643A1 (en) 2011-07-20
JP2013515755A (ja) 2013-05-09
AU2010338267A1 (en) 2012-07-19
MA33829B1 (fr) 2012-12-03
ZA201204347B (en) 2013-09-25
SMT201500182B (it) 2015-09-07
CN105384685A (zh) 2016-03-09
CA2783213C (en) 2017-09-12
EP2519505A1 (en) 2012-11-07
AU2010338267B2 (en) 2014-03-27
ECSP12012007A (es) 2012-08-31
GEP20156244B (en) 2015-02-10
US20120309751A1 (en) 2012-12-06
CY1116493T1 (el) 2017-03-15
US8729098B2 (en) 2014-05-20
KR20120101563A (ko) 2012-09-13
DK2519505T3 (en) 2015-06-29
KR101666505B1 (ko) 2016-10-14
JP5808754B2 (ja) 2015-11-10
CL2012001757A1 (es) 2013-03-22
PL2519505T3 (pl) 2015-11-30
CN102686566A (zh) 2012-09-19

Similar Documents

Publication Publication Date Title
NI201400107A (es) Compuestos de heterociclilo como inhibidores de mek
CR20150370A (es) Compuestos antivirales
GT201200216A (es) Nuevos derivados terciarios de 8-hidroxiquinolina-7carboxamida y usos de los mismos.
CO6771439A2 (es) Inhibidores de benzodioxano de la producción de leucotrieno
GT201400131A (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
UY34917A (es) Inhibidores de la producción de leucotrieno-a4-hidrolasa (lta4h), composiciones farmacéuticas que los contienen y proceso para su preparación
GT201400063A (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
UY35177A (es) Novedosos derivados de bencimidazol como antagonistas de ep4
UY33536A (es) INHIBIDORES BICÍCLICOS DE ACETIL-CoA-CARBOXILASA Y USOS DE LOS MISMOS
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
PE20180318A1 (es) Procedimiento para preparar isoquinolinonas y formas solidas de isoquinolinonas
CR11623A (es) Compuestos
ECSP15012804A (es) Alcoxipirazoles como activadores de guanilato ciclasa soluble
ECSP14013215A (es) Compuestos novedosos
CR20140554A (es) Compuestos de acido dimetil-benzoico
CU20150021A7 (es) Piridinonas bicíclicas novedosas
ECSP11011391A (es) Métodos y productos intermedios para preparar agentes farmacéuticos
CR20140553A (es) Compuestos de fenoxietil piperidina
MX2020004283A (es) Derivados de piridincarbonilo y usos terapéuticos de los mismos como inhibidores de trpc6.
UY32977A (es) Novedosos compuestos como inhibidores de la caseina quinasa
DOP2016000276A (es) 2-AMINO-6-METIL-4,4a,5,6-TETRAHIDROPIRANO[3,4-d][1,3]TIAZIN-8a(8H)-IL-1,3-TIAZOL-4-ILAMIDAS
ECSP11010992A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales
ECSP11011485A (es) Espiro-epóxidos como productos intermedios.
CR20110680A (es) Sulfonamidas heterociclicas, usos y composiciones farmacéuticas de las mismas
UY32754A (es) NUEVOS DERIVADOS DE 1,2,3,4-TETRAHIDRO-PIRIMIDO{1,2-a}PIRIMIDIN-6-ONA, SU PREPARACIÓN Y SU UTILIZACIÓN EN FARMACÉUTICA